[Skip to Content]
[Skip to Content Landing]
Other Articles
February 6, 1937


JAMA. 1937;108(6):476-478. doi:10.1001/jama.1937.02780060042012

Two bills1 are now pending in Congress, each drafted with a view to the removal of the weaknesses inherent in the Food and Drugs Act of 1906. Each bill is designed, however, to go further and (1) to establish standards of purity for cosmetics, (2) to establish standards of truthfulness for the labeling and advertising of cosmetics and prophylactic and therapeutic devices, and (3) to establish methods of law enforcement more effective than those now authorized. Each of these bills is better calculated to protect and promote the public health and to enforce care, skill and honesty in manufacturing and merchandising than were the corresponding bills passed by the Senate and the House of Representatives in the Seventy-Fourth Congress, which failed in conference. There is, however, still much room for needed improvement.

Each bill, for instance, proposes to authorize every manufacturer and dealer in drugs who is within its

First Page Preview View Large
First page PDF preview
First page PDF preview